NRBO - NeuroBo Pharmaceuticals Inc Stock Price, Fair Value and News

$1.76-0.09 (-4.86%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

NRBO Price Action

Last 7 days

-5.2%

Last 30 days

-14.4%

Last 90 days

-39.3%

Trailing 12 Months

-45.1%

NRBO RSI Chart

NRBO Valuation

Market Cap

15.2M

Price/Earnings (Trailing)

-0.55

EV/EBITDA

0.24

Price/Free Cashflow

-0.67

MarketCap/EBT

-0.55

NRBO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NRBO Fundamentals

NRBO Earnings

Earnings (TTM)

-27.7M

Earnings Growth (Yr)

-48.04%

Earnings Growth (Qtr)

43.78%

NRBO Profitability

Return on Equity

-214.1%

Return on Assets

-125.23%

Free Cashflow Yield

-149.76%

NRBO Investor Care

Shares Dilution (1Y)

77.59%

Diluted EPS (TTM)

-4.77

Revenue & Growth

About NeuroBo Pharmaceuticals Inc

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity. The company also develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

CEO	Mr. Hyung-Heon Kim
WEBSITE	neurobopharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	2

NeuroBo Pharmaceuticals Inc Frequently Asked Questions

What is the ticker symbol for NeuroBo Pharmaceuticals Inc? What does NRBO stand for in stocks?

NRBO is the stock ticker symbol of NeuroBo Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NeuroBo Pharmaceuticals Inc (NRBO)?

As of Thu Dec 19 2024, market cap of NeuroBo Pharmaceuticals Inc is 15.16 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NRBO stock?

You can check NRBO's fair value in chart for subscribers.

Is NeuroBo Pharmaceuticals Inc a good stock to buy?

The fair value guage provides a quick view whether NRBO is over valued or under valued. Whether NeuroBo Pharmaceuticals Inc is cheap or expensive depends on the assumptions which impact NeuroBo Pharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NRBO.